Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Ocul Immunol Inflamm. 2021 Mar 4;30(5):1039–1043. doi: 10.1080/09273948.2020.1859549

Table 5:

Clinical characteristics of incident versus prevalent presumed ocular histoplasmosis (POHS) cases.

Incident POHS cases
(N=18)
Prevalent POHS cases
(N=79)
All POHS cases
(N=97)
Number of affected eyes 30 131 161
Choroidal neovascularization 4 (13.3%) 24 (18.3%) 28 (17.4%)
Snellen visual acuity at last follow-up
20/20 to 20/40 26 (86.7%) 84 (64.1%) 110 (68.3%)
20/50 to 20/150 4 (13.3%) 22 (16.8%) 26 (16.1%)
20/200 or worse 0 (0%) 25 (19.1%) 25 (15.5%)
Visual acuity <20/40 due to POHS 0 (0%) 27 (20.6%) 27 (16.8%)

N = number of patients.